Skip to content

AI-assisted sleep apnea full-process management and comprehensive prevention and treatment research

Research on AI-based Comprehensive Management of Obstructive Sleep Apnea Throughout the Disease Course and Integrated Prevention and Control System for Multi-system Damage: A Prospective Multi-center Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111067
Enrollment
Unknown
Registered
2025-10-24
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea (OSA)

Interventions

AI Course Management Group:Application of AI driven full course management path.
Routine course management group:Maintain the existing diagnosis and treatment management process.

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The age is 18-75 years old (including the boundary value). 2. Primary school education or above. 3. Patients diagnosed with obstructive sleep apnea (that is, meet the diagnostic criteria of the Guidelines for the Grassroots Diagnosis and Treatment of Adult Obstructive Sleep and Respiratory Disorders (2018 Edition) issued by the Chinese Medical Association in 2018: Apnea Hyponea Index (AHI) >=15 Second/h, mainly blocking events). 4. Voluntarily receive home non-invasive ventilator treatment, have good cognition, can correctly switch on and off the machine and wear a nose mask. 5. Have an intelligent terminal (such as a smartphone/tablet/computer, etc.), and know how to use WeChat and other software. 6. Participate in this study voluntarily and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have received ventilator treatment in the past 3 months. 2. Participating in other clinical trials. 3. Acute inflammatory reaction period. 4. Suffering from tuberculosis, AIDS, syphilis and other infectious diseases. 5. Those who are unable to cooperate to complete various inspections and inspections. 6. Vulnerable groups, including people with mental illness, people with cognitive impairment, critically ill patients, pregnant women, illiterate people, etc. 7. Others are considered unsuitable to participate in this researcher after evaluation by the researcher.

Design outcomes

Primary

MeasureTime frame
NPPV compliance (i.e. the ratio of use time >4h/night);AHI decline compared with the baseline;

Secondary

MeasureTime frame
Minimum/average blood oxygen, blood pressure, fasting blood glucose, weight;

Countries

China

Contacts

Public ContactZhou Yong

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

zhouybox@163.com+86 571 8600 6192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026